Stem cell research may offer a glimmer of hope for the future treatment of Lou Gehrig’s disease. A new study examines its safety in humans.
New animal research has shown that measuring copper concentrations and isotope ratios in blood and other tissue may allow early diagnosis of Amyotrophic lateral sclerosis (ALS).
Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, has reported positive data from preclinical studies of its PLX-PAD cells in the treatment of Duchenne…
New research reveals how infection with the parasite Toxoplasma gondii could trigger neurodegenerative diseases in those predisposed to the conditions.
Fresh insights into how our cells control muscle development could aid understanding of muscular dystrophy and other inherited diseases.
A brain enzyme that protects against oxidative stress may also protect against protein clump formation – a key player in neurodegenerative disease.
Johns Hopkins researchers report they have inadvertently found a way to make human muscle cells bearing genetic mutations from people with Duchenne muscular dystrophy (DMD).
Canine Degenerative Myelopathy (DM) is a neurodegenerative disease in dogs with similarities to ALS in humans.
The growth factor IGF-2 can prevent the death of human nerve cells in the incurable disease ALS, according to a study by researchers at Sweden´s Karolinska Institutet and the University of Milan…
The risk of ALS, or Lou Gehrig’s disease, may be increased with residential or occupational exposure to pesticides, according to new research.